Phase
Condition
Macular Degeneration
Geographic Atrophy
Treatment
PF-05206388
Clinical Study ID
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and /or post-menopausal female subjects aged 60 years or above.
Diagnosis of wet Age-related Macular Degeneration (AMD) plus rapid recent visiondecline
An informed consent document signed and dated by the subject or a legalrepresentative.
Exclusion
Exclusion Criteria:
Pregnant females; breastfeeding females; and females of childbearing potential.
Treatment with an investigational drug within 30 days (or as determined by the localrequirement, whichever is longer) or 5 half-lives preceding the first dose of studymedication.
Current or previous significant other ocular disease in the study eye, as determinedby the investigator.
Study Design
Study Description
Connect with a study center
Moorfields Eye Hospital NHS Foundation Trust
London, EC1V 2PD
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.